Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man. 1987

N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
Institute for Medical Virology and Immunology, University of Essen Medical School.

Purified Chick Embryo Cell (PCEC) rabies vaccine was given to 88 healthy adults according to six different vaccination schedules. Local side effects were reported on reactivity forms after 16.4% of PCECV injections, general symptoms were recorded after 15.1% of the 292 doses administered. IgE antibodies specific for chicken proteins determined by the Radio Allergo Sorbens Test (RAST) could not be shown before and after the vaccinations. With no exception, all 88 vaccinees developed high titres of complement-fixing and neutralizing antibodies as determined by the Rapid Fluorescent Focus Inhibition Test and Serum Mouse Neutralization Test. For the first time, induction of serum interferon by PCEC rabies vaccine has been shown in man. In rabies vaccination, PCEC vaccine seems to be as effective as Human Diploid Cell Strain (HDCS) vaccine.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008297 Male Males
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
October 1989, Vaccine,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
November 1984, Behring Institute Mitteilungen,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
November 1984, Behring Institute Mitteilungen,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
January 1986, Lancet (London, England),
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
February 1990, Vaccine,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
July 2003, The Journal of the Association of Physicians of India,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
February 1994, Indian pediatrics,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
December 1997, Vaccine,
N Scheiermann, and J Baer, and J Hilfenhaus, and I Marcus, and G Zoulek
November 1994, Vaccine,
Copied contents to your clipboard!